Taysha Gene Therapies

Taysha Gene Therapies is a biotechnology company focused on developing and commercializing gene therapies for the treatment of monogenic diseases of the central nervous system (CNS). They make money by advancing a robust pipeline of gene therapy candidates through clinical trials and partnering with other biotech and pharmaceutical companies. Founded in 2019 and headquartered in Dallas, Texas, Taysha has a strategic collaboration with the University of Texas Southwestern Medical Center, which provides access to cutting-edge research and development capabilities.

Recent Posts by Taysha Gene Therapies

1-2 of 2